Hypercalcemia
📧 Sign up to get email alerts when something new happens for Hypercalcemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-04FDA Approved: CALCITONIN SALMON — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves Zydus Pharmaceuticals USA Inc.'s Original Application for Calcitonin Salmon, a generic version of the established drug. This ap…
-
EMA approval · 2026-02-24EMA Authorised: Zoledronic Acid Accord (zoledronic acid monohydrate) — Accord Healthcare S.L.U.
The EMA authorised Zoledronic Acid Accord (zoledronic acid monohydrate) for hypercalcemia, prevention of fractures in bone disorders, and ca…
-
EMA approval · 2025-10-07EMA Authorised: Cinacalcet Viatris (previously Cinacalcet Mylan) (cinacalcet hydrochloride) — Mylan Pharmaceuticals Limited
EMA authorised Cinacalcet Viatris (cinacalcet hydrochloride) for secondary hyperparathyroidism and hypercalcemia, with Mylan Pharmaceuticals…
-
FDA approval · 2025-09-26FDA Approved: CALCITONIN SALMON — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for Calcitonin Salmon (generic), marking the entry of a generic calcitonin product…
-
FDA approval · 2024-12-05FDA Approved: CALCITONIN SALMON — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's Calcitonin Salmon as an original application (ANDA 212675), enabling the marketing of this generic ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2024-09-16EMA Authorised: Bondronat (ibandronic acid) — Atnahs Pharma Netherlands B.V.
EU marketing authorisation granted to Bondronat (ibandronic acid) for hypercalcemia, breast cancer with bone metastases, and bone-related fr…
-
EMA approval · 2024-08-30EMA Authorised: Iasibon (ibandronic acid) — Pharmathen S.A.
EMA authorised Iasibon (ibandronic acid) for hypercalcemia, prevention of bone fractures, and cancer-related indications involving metastati…
-
EMA approval · 2024-06-06EMA Authorised: Mimpara (cinacalcet hydrochloride) — Amgen Europe B.V.
The European Medicines Agency authorised Mimpara (cinacalcet hydrochloride) for indications including hypercalcemia, parathyroid neoplasms, …
-
FDA approval · 2024-04-11FDA Approved: CALCITONIN SALMON — Original Application (Dr. Reddy's Laboratories, Inc.)
FDA approved the original application for Calcitonin Salmon from Dr. Reddy's Laboratories, Inc., enabling the generic to enter the market.
-
FDA approval · 2022-01-27FDA Approved: FUROSEMIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved an original generic application for furosemide from Meitheal Pharmaceuticals Inc.
-
FDA approval · 2021-11-10FDA Approved: CALCITONIN SALMON — Original Application (Par Health USA, LLC)
The FDA approved Par Health USA's generic Calcitonin Salmon under ANDA 209358.
-
EMA approval · 2021-11-09EMA Authorised: Zoledronic Acid Hospira (zoledronic acid monohydrate) — Pfizer Europe MA EEIG
EU authorises Zoledronic Acid Hospira (zoledronic acid monohydrate) for hypercalcemia.
-
FDA approval · 2021-05-14FDA Approved: CALCITONIN SALMON — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original application for a generic Calcitonin Salmon product (ANDA 212416).
-
FDA approval · 2015-10-31FDA Approved: CALCITONIN SALMON — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for calcitonin salmon (generic), resulting in an updated approval under the ANDA p…
-
FDA approval · 2015-10-31FDA Approved: CALCITONIN SALMON — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Calcitonin Salmon submitted by Endo USA, Inc.
-
FDA approval · 2015-02-02FDA Approved: MIACALCIN — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for Miacalcin (calcitonin salmon) submitted by Mylan Institutional LLC.
-
FDA approval · 2013-02-19FDA Approved: MIACALCIN — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for Miacalcin (calcitonin salmon) submitted by Mylan Institutional LLC. The action pertains to a…
-
FDA approval · 2012-07-12FDA Approved: CALCITONIN SALMON — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Calcitonin Salmon from Endo USA, Inc.
-
FDA approval · 2012-04-25FDA Approved: CALCITONIN SALMON — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for Calcitonin Salmon from Apotex Corp., updating the approved product's regulatory status.
-
FDA approval · 2011-08-01FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)
The FDA approves a supplemental application for Sensipar (cinacalcet hydrochloride) submitted by Amgen Inc.
-
FDA approval · 2009-11-12FDA Approved: SENSIPAR — Supplemental Application (Amgen Inc)
The FDA approved Amgen's supplemental application for SENSIPAR (cinacalcet hydrochloride), resulting in updated labeling for the product.
-
FDA approval · 2009-06-08FDA Approved: CALCITONIN SALMON — Original Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s Original Application for Calcitonin Salmon (generic), confirming a generic product for the drug. The approval …
-
FDA approval · 2008-11-17FDA Approved: CALCITONIN SALMON — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original ANDA for Calcitonin Salmon, authorizing a generic version of the drug for its approved uses.
-
FDA approval · 2006-07-14FDA Approved: PAMIDRONATE DISODIUM — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for pamidronate disodium submitted by Hospira, Inc. The action approves changes associated with the …